A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance
- 1 November 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 17 (11) , 1627-1631
- https://doi.org/10.1097/00004872-199917110-00017
Abstract
To compare enalapril 20 mg once daily with 10 mg twice daily in terms of blood pressure reduction and patient compliance. Cross-over study of patients randomly assigned to a sequence of enalapril 20 mg once daily or 10 mg twice daily in three 4-week periods following a 4-week placebo run-in. General practices in the greater Belfast and Lisburn area in Northern Ireland. Twenty-five hypertensive patients who had a mean diastolic blood pressure of between 90 and 110 mmHg after receiving placebo for 4 weeks. Reduction in blood pressure and estimation of patient compliance. Patient compliance was superior on the once daily regimen. However, the twice daily regimen was associated with a greater blood pressure reduction which almost reached statistical significance at the 5% level. Enalapril 20 mg should be prescribed as 10 mg twice daily and measures taken to improve patient compliance.Keywords
This publication has 11 references indexed in Scilit:
- Patient compliance and therapeutic coverage: comparison of amlodipine and slow release nifedipine in the treatment of hypertensionEuropean Journal of Clinical Pharmacology, 1995
- Use of drugs with more than a twenty-four-hour duration of actionJournal Of Hypertension, 1994
- Prediction of the antihypertensive response to enalaprilJournal Of Hypertension, 1990
- Good Clinical Practice for Trials on Medicinal Products in the European Community: CPMP Working Party on Efficacy of Medicinal ProductsBasic & Clinical Pharmacology & Toxicology, 1990
- The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systemsJournal Of Hypertension, 1990
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextPublished by Elsevier ,1990
- Kinetic-dynamic relations and individual responses to enalapril.Hypertension, 1990
- The end of the p value?Heart, 1988
- Antihypertensive and metabolic effects of a new converting enzyme inhibitor, enalaprilClinical Pharmacology & Therapeutics, 1983
- Effects of enalapril, a new converting enzyme inhibitor, in hypertensionClinical Pharmacology & Therapeutics, 1982